Predictive Oncology (POAI) Institutional Ownership $1.27 +0.06 (+4.96%) Closing price 04:00 PM EasternExtended Trading$1.28 +0.01 (+0.79%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Predictive Oncology (NASDAQ:POAI)CurrentInstitutional OwnershipPercentage9.04%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$34.08KNumber ofInstitutional Sellers(last 12 months)0 Get POAI Insider Trade Alerts Want to know when executives and insiders are buying or selling Predictive Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data POAI Institutional Buying and Selling by Quarter Predictive Oncology Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/2/2024Carnegie Mellon University10,358$34K0.0%N/A0.255% 10/24/2023Raymond James & Associates118,229$378K0.0%N/A2.934% 8/8/2023RB Capital Management LLC20,835$101K0.0%-95.0%0.525% 8/1/2023Carnegie Mellon University10,358$50K0.1%-95.0%0.261% 5/10/2023RB Capital Management LLC416,693$136K0.0%+161.2%10.496% 2/6/2023 Sax Wealth Advisors LLC147,437$45K0.0%+37.2%0.187% 8/11/2022 Sax Wealth Advisors LLC107,437$44K0.0%N/A0.162% 7/14/2022RB Capital Management LLC159,500$65K0.0%N/A0.241% 11/9/2021BlackRock Inc.160,629$214K0.0%+12.9%0.246% 8/17/2021Price T Rowe Associates Inc. MD106,200$139K0.0%N/A0.162% 8/16/2021State Street Corp298,632$391K0.0%N/A0.457% 8/13/2021Geode Capital Management LLC414,705$543K0.0%+198.4%0.635% 8/13/2021Vanguard Group Inc.1,838,085$2.41M0.0%+231.9%2.813% 8/12/2021Private Advisor Group LLC26,805$35K0.0%+84.0%0.041% 5/19/2021Virtu Financial LLC82,810$100K0.0%N/A0.166% 5/17/2021Armistice Capital LLC2,051,284$2.48M0.1%N/A4.117% 5/17/2021Goldman Sachs Group Inc.164,258$199K0.0%N/A0.330% 5/13/2021Renaissance Technologies LLC593,267$718K0.0%N/A1.191% 5/13/2021Bank of New York Mellon Corp37,348$45K0.0%N/A0.075% 5/12/2021Northern Trust Corp67,289$81K0.0%+343.4%0.135% 5/12/2021Geode Capital Management LLC138,973$168K0.0%N/A0.279% 5/11/2021Maryland Capital Management46,000$56K0.0%N/A0.092% (Data available from 1/1/2016 forward) POAI Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of POAI shares? During the previous two years, the following institutional investors and hedge funds held shares of Predictive Oncology shares: Raymond James & Associates ($378K), RB Capital Management LLC ($101K), and Sax Wealth Advisors LLC ($45K), Carnegie Mellon University ($34K).Learn more on POAI's institutional investors. What percentage of Predictive Oncology stock is owned by institutional investors? 9.04% of Predictive Oncology stock is owned by institutional investors. Learn more on POAI's institutional investor holdings. Which institutional investors have been buying Predictive Oncology stock? The following institutional investors have purchased Predictive Oncology stock in the last 24 months: RB Capital Management LLC ($257.19K), Raymond James & Associates ($118.23K), Sax Wealth Advisors LLC ($40K), and Carnegie Mellon University ($10.36K). How much institutional buying is happening at Predictive Oncology? Institutional investors have bought a total of 425,780 shares in the last 24 months. This purchase volume represents approximately $2.34M in transactions. Which Predictive Oncology major shareholders have been selling company stock? The following institutional investors have sold Predictive Oncology stock in the last 24 months: RB Capital Management LLC ($395.86K), and Carnegie Mellon University ($196.79K). How much institutional selling is happening at Predictive Oncology? Institutional investors have sold a total of 592,644 shares in the last 24 months. This volume of shares sold represents approximately $2.88M in transactions. Related Companies Nexalin Technology Institutional Ownership Envoy Medical Institutional Ownership SurgePays Institutional Ownership Precision Optics Institutional Ownership IRIDEX Institutional Ownership DarioHealth Institutional Ownership Beyond Air Institutional Ownership Co-Diagnostics Institutional Ownership BioSig Technologies Institutional Ownership Femasys Institutional Ownership This page (NASDAQ:POAI) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredThis coin could surge during Trump’s first week in office.Juan has never had a losing trade on Bitcoin. And he booked gains of 312% on Chainlink … Now, he says one v...Weiss Ratings | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAltcoin season moves fast, and those who hesitate are left behind. The window is closing.Crypto Swap Profits | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Predictive Oncology Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Predictive Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
